ABSI - Latest News

Absci Corporation (ABSI), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $1.70B. Beta to the broader market is 2.46.

The article list below shows the most recent ABSI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ABSI Headlines

ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss Study

zacks.com - Jun 25, 2026

Absci stock jumps 36% as interim phase I hair loss study data show ABS-201 is well tolerated and pharmacokinetics support the potential for infrequent

ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?

zacks.com - Jun 25, 2026

ABSCI CORP (ABSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for t

Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program

benzinga.com - Jun 24, 2026

Absci Corporation (NASDAQ:ABSI) stock is trading higher on Wednesday after the company reported positive interim Phase 1 results for its investigation

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

globenewswire.com - Jun 24, 2026

Eli Lilly & Company, Adage, BVF Partners, Columbia Threadneedle, Invus, Redmile, and large investment management firm invest $100 million in Absci

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

globenewswire.com - Jun 24, 2026

Study medication appears well tolerated, with favorable safety data across all blinded single ascending dose (SAD) cohorts

How News Affects ABSI Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ABSI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ABSI news questions

What is the latest ABSI news headline?

The most recent ABSI headline (Jun 25, 2026) is "ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss Study". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ABSI news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ABSI news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ABSI options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.